BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22439735)

  • 1. Scleroderma-like syndrome due to hydroxyurea.
    García-Martínez FJ; García-Gavín J; Alvarez-Pérez A; Alonso-González J; Ginarte M; Toribio J
    Clin Exp Dermatol; 2012 Oct; 37(7):755-8. PubMed ID: 22439735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
    Olesen LH; Pedersen BB
    Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pemetrexed-induced scleroderma-like changes in the lower legs].
    Corbaux C; Marie J; Meraud JP; Lacroix S; Delhoume JY; Jouary T; Madoui S
    Ann Dermatol Venereol; 2015 Feb; 142(2):115-20. PubMed ID: 25554663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyurea induced dermatomyositis-like eruption.
    Zappala TM; Rodins K; Muir J
    Australas J Dermatol; 2012 Aug; 53(3):e58-60. PubMed ID: 22881475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bilateral leg ulcers with pathologic evidence of small vessel vasculitis by skin biopsy during hydroxyurea therapy of chronic myelogenous leukemia].
    Tomiyama J; Yano K; Uchino S; Ito T; Kudo H; Irimajiri J; Ohkubo H; Kanazawa A; Kawahara Y
    Rinsho Ketsueki; 1997 Mar; 38(3):231-3. PubMed ID: 9095664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine-induced acute lipodermatosclerosis-like reaction.
    Chu CY; Yang CH; Chiu HC
    Acta Derm Venereol; 2001; 81(6):426-8. PubMed ID: 11859947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN.
    Antonioli E; Guglielmelli P; Pieri L; Finazzi M; Rumi E; Martinelli V; Vianelli N; Luigia Randi M; Bertozzi I; De Stefano V; Za T; Rossi E; Ruggeri M; Elli E; Cacciola R; Cacciola E; Pogliani E; Rodeghiero F; Baccarani M; Passamonti F; Finazzi G; Rambaldi A; Bosi A; Cazzola M; Barbui T; Vannucchi AM;
    Am J Hematol; 2012 May; 87(5):552-4. PubMed ID: 22473827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatomyositis-like eruption after long-term hydroxyurea therapy for polycythemia vera.
    Oskay T; Kutluay L; Ozyilkan O
    Eur J Dermatol; 2002; 12(6):586-8. PubMed ID: 12459535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gottron-like papules induced by hydroxyurea.
    Agrawal PG; Mahajan SA; Khopkar US; Kharkar VD
    Indian J Dermatol Venereol Leprol; 2012; 78(6):775. PubMed ID: 23075664
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema.
    Ito E; Muro Y; Shibata A; Sugiura K; Akiyama M
    Dermatol Online J; 2014 Aug; 20(8):. PubMed ID: 25148281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gottron-like papules induced by hydroxyurea.
    Yoshida K; Saito M; Amagai M; Ikeda Y
    Clin Exp Dermatol; 2005 Mar; 30(2):191-2. PubMed ID: 15725256
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary cutaneous effects of hydroxyurea: possible pathogenetic mechanisms.
    Zaccaria E; Cozzani E; Parodi A
    J Dermatolog Treat; 2006; 17(3):176-8. PubMed ID: 16854761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleroderma-like skin changes induced by checkpoint inhibitor therapy.
    Tjarks BJ; Kerkvliet AM; Jassim AD; Bleeker JS
    J Cutan Pathol; 2018 Aug; 45(8):615-618. PubMed ID: 29740855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anhidrosis during long-term hydroxyurea therapy in a patient with chronic myelogenous leukemia].
    Takagi K; Nakamura T; Misaki H; Ueda T
    Rinsho Ketsueki; 2000 Nov; 41(11):1214-9. PubMed ID: 11193442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methysergide-induced scleroderma-like changes of the legs.
    Kluger N; Girard C; Bessis D; Guillot B
    Br J Dermatol; 2005 Jul; 153(1):224-5. PubMed ID: 16029366
    [No Abstract]   [Full Text] [Related]  

  • 16. Cutaneous manifestations of hydroxyurea therapy in childhood: case report and review.
    Issaivanan M; Mitu PS; Manisha C; Praveen K
    Pediatr Dermatol; 2004; 21(2):124-7. PubMed ID: 15078351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myositis caused by hydroxyurea in a patient with chronic myelogenous leukemia].
    Ikeda K; Mita M; Ishibashi T; Shichishima T; Maruyama Y
    Rinsho Ketsueki; 1998 Sep; 39(9):676-9. PubMed ID: 9796402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin lesion caused by hydroxyurea.
    Hirri HM; Green PJ
    Eur J Haematol; 2001; 67(5-6):328-9. PubMed ID: 11872082
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous ulcerations on hands and heels secondary to long-term hydroxyurea treatment.
    Friedrich S; Raff K; Landthaler M; Karrer S
    Eur J Dermatol; 2004; 14(5):343-6. PubMed ID: 15358575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple squamous cell carcinomas of the skin during long-term treatment with hydroxyurea.
    De Simone C; Guerriero C; Guidi B; Rotoli M; Venier A; Tartaglione R
    Eur J Dermatol; 1998 Mar; 8(2):114-5. PubMed ID: 9649662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.